LymphaTech
Mike Weiler is a Co-Founder and CEO of LymphaTech Inc. since August 2014. Prior to that, they were a National Science Foundation Graduate Research Fellow at the Georgia Institute of Technology from August 2010 to July 2015. During this time, they developed a near-infrared imaging diagnostic to detect lymphedema, resulting in 2 publications and 3 conference presentations. Mike also participated in the Technological Innovation: Generating Economic Results (TI:GER) program, forming an LLC called LymphaTech, which is developing an optical diagnostic for lymphedema detection and prevention. Additionally, they were an Undergraduate Product Development Engineer at Georgia Tech, where they filed a preliminary patent for a red blood cell filtration device. Mike was also an Undergraduate Research Assistant in the Cardiovascular Fluid Mechanics Lab, leading a team of students. Mike was a Young Entrepreneurs Program Fellow at Foundation Capital, responsible for identifying promising startups and building relationships between entrepreneurs and the company. Mike worked as a Business Intelligence Intern at MedShape, Inc. in 2013. In 2009, they were a Research Assistant in the Orthopedic Biomechanics Lab at Inova Health System, where they conducted mechanical testing of fracture fixation methods, provided advice to surgeons, and presented research at orthopedic conferences.
Mike Weiler earned a Bachelor of Science degree in Biomedical Engineering from Georgia Institute of Technology in 2010. Mike then pursued a Master of Science degree in Mechanical Engineering from the same institution from 2010 to 2012. Following this, Mike Weiler completed a PhD in Bioengineering at Georgia Institute of Technology, from 2010 to 2015.
This person is not in any teams
LymphaTech
1 followers
LymphaTech is a healthcare technology company aimed at treating and preventing lymphedema. LymphaTech’s 3D body scanning technology is designed to allow doctors to diagnose lymphedema more promptly, while there’s still time to provide effective treatment. The 3D scan, which can be performed at home or in the doctor’s office, tracks changes in limbvolume over time. This detects symptoms early so patients can quickly receive targeted treatment. LymphaTech’s solution would improve the quality of life for many breast cancer survivors and meet an important need for clinicians and patients.The company was founded in 2014 and is based in Atlanta, Georgia.